Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia

por Walter, Wencke, Shahswar, Rabia, Stengel, Anna, Meggendorfer, Manja, Kern, Wolfgang, Haferlach, Torsten, Haferlach, Claudia
Publicado 2021

Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up

por Shahswar, Rabia, Beutel, Gernot, Gabdoulline, Razif, Koenecke, Christian, Markel, Dominik, Eder, Matthias, Stadler, Michael, Gohring, Gudrun, Schlegelberger, Brigitte, Trummer, Arne, Krauter, Juergen, Thol, Felicitas, Heuser, Michael
Publicado 2020

S123: ACUTE MYELOID LEUKEMIA STEM CELL SUBTYPES DEFINED BY MUTATIONS AND DIFFERENTIATION STATE REGULATE APOPTOTIC DEPENDENCY AND CLINICAL RESPONSE TO VENETOCLAX.

por Waclawiczek, Alexander, Leppä, Aino-Maija, Renders, Simon, Betz, Barbara, Stumpf, Karolin, Jansen, Maike, Merbach, Anne Kathrin, Shahswar, Rabia, Röllig, Christoph, Heuser, Michael, Sauer, Tim, Müller-Tidow, Carsten, Trumpp, Andreas
Publicado 2023

P408: COMBINATORIAL BCL-2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX

por Renders, Simon, Waclawiczek, Alexander, Leppä, Aino-Maija, Stumpf, Karolin, Betz, Barbara, Reyneri, Cecilia, Donato, Elisa, Janssen, Maike, Unglaub, Julia, Shahswar, Rabia, Raffel, Simon, Hundemer, Michael, Heuser, Michael, Müller-Tidow, Carsten, Sauer, Tim, Trumpp, Andreas
Publicado 2023

P510: PREDICTORS OF RESPONSE AND OUTCOME IN PATIENTS WITH REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA RECEIVING VENETOCLAX WITH NON-INTENSIVE CHEMOTHERAPY

por Krüger, Katja, Wichmann, Martin, Gabdoulline, Razif, Götze, Katharina, Braitsch, Krischan, Modemann, Franziska, Fiedler, Walter, Trummer, Arne, Krauter, Jürgen, Kaun, Stephan, Rotermund, Susanne, Voß, Andreas, Goehring, Gudrun, Behrens, Yvonne, Thol, Felicitas, Eder, Matthias, Beutel, Gernot, Stadler, Michael, Heuser, Michael, Shahswar, Rabia
Publicado 2023

Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax

por Waclawiczek, Alexander, Leppä, Aino-Maija, Renders, Simon, Stumpf, Karolin, Reyneri, Cecilia, Betz, Barbara, Janssen, Maike, Shahswar, Rabia, Donato, Elisa, Karpova, Darja, Thiel, Vera, Unglaub, Julia M., Grabowski, Susanna, Gryzik, Stefanie, Vierbaum, Lisa, Schlenk, Richard F., Röllig, Christoph, Hundemer, Michael, Pabst, Caroline, Heuser, Michael, Raffel, Simon, Müller-Tidow, Carsten, Sauer, Tim, Trumpp, Andreas
Publicado 2023